ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,024, issued on June 24, was assigned to Interlude Biopharma Co. (Miami).
"Larazotide formulations" was invented by Balasingham Radhakrishnan (Raleigh, N.C.), Jay P. Madan (Raleigh, N.C.) and Gary F. Musso (Raleigh, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, in part, compositions comprising a peptide that is larazotide or larazotide derivative, or salt thereof, contained within a matrix that provides for controlled release and sustained release formulations. The present invention contemplates that these compositions, formulations and methods can be useful for treating diseases and disorders of the small bowel....